APOE rs8103922: Understanding Your Genetic Context
The rs8103922 variant is located within the APOE gene, a region extensively studied for its role in Alzheimer's disease risk. This variant serves as a genetic marker used in research to better understand the complex neuropathology associated with cognitive decline.
What each genotype means
Average risk profile
This genotype corresponds to the APOE e3/e3 status, which is considered the most common and neutral baseline for Alzheimer's disease risk. It does not confer the increased risk associated with the e4 allele or the potential protective effects of the e2 allele. Having this genotype does not guarantee you will not develop Alzheimer's disease, as other genetic and environmental factors play significant roles.
This is the most common genotype found in most global populations.
Increased risk profile
This genotype corresponds to the APOE e3/e4 status, which is associated with a statistically higher risk of developing late-onset Alzheimer's disease compared to the e3/e3 genotype. While this variant is a significant marker for risk, it is not a diagnostic test and many individuals with this genotype never develop the condition. You should discuss any concerns about cognitive health or family history with your healthcare provider.
Carried by a significant portion of the population, with frequencies varying by ancestry, often observed in approximately 20-25% of individuals of European descent.
Elevated risk profile
This genotype corresponds to the APOE e4/e4 status, which is associated with the highest statistical risk for late-onset Alzheimer's disease among the common APOE variants. This genotype is a risk factor rather than a deterministic cause, meaning it increases the likelihood of developing the disease but does not make it inevitable. Clinical guidelines generally advise against using this information for predictive testing in asymptomatic individuals; consult your physician for personalized health guidance.
This is a less common genotype, typically found in approximately 2-3% of the general population, though frequencies vary significantly across different ancestral groups.
What is rs8103922 and Where is it Located?
The rs8103922 variant is a single nucleotide polymorphism (SNP) situated within the APOE gene on chromosome 19. In genomics, SNPs represent the most common type of genetic variation, where a single building block of DNA—a nucleotide—differs between individuals. The APOE gene is highly significant in human genetics because it provides instructions for making a protein called apolipoprotein E. This protein is essential for the transport of cholesterol and other fats through the bloodstream. Because of its critical role in lipid metabolism and its expression in the brain, researchers closely monitor variations in this region to determine how they might influence cellular health and long-term neurological function. While rs8103922 is just one of many markers in this locus, it is frequently included in genomic studies that utilize advanced statistical models to map the relationship between specific DNA sequences and complex health traits.
The Role of the APOE Gene
The APOE gene is best known for its influence on the risk of late-onset Alzheimer's disease. The protein it produces, apolipoprotein E, helps clear amyloid-beta peptides from the brain, which are proteins that can form harmful plaques in the brains of individuals with Alzheimer's. Variations in this gene can alter the efficiency of this clearance process or affect how neurons maintain their structure and function. While the most famous variants in this gene are the epsilon alleles (e2, e3, and e4), the entire APOE locus is a hotspot for research. Scientists study markers like rs8103922 to understand how the broader genetic architecture of this region contributes to individual differences in brain health. By analyzing these variations, researchers aim to build a more complete picture of how genetic inheritance influences the biological pathways that lead to neurodegenerative conditions over a person's lifespan.
Research Associations and Evidence Strength
The evidence linking specific APOE variants to Alzheimer's disease is robust, though the specific contribution of individual markers like rs8103922 is often evaluated within the context of the entire gene. Research using genomic informational field theory and other statistical methods has identified this variant as a significant marker associated with Alzheimer's disease neuropathology. However, it is important to note that genetic associations are not diagnostic. Having a particular genotype at this location does not guarantee that an individual will develop a disease, nor does the absence of a marker guarantee protection. Current research emphasizes that Alzheimer's is a multifactorial condition influenced by a combination of genetics, lifestyle, and environmental factors. The strength of evidence for any single SNP can vary depending on the population studied, and scientists continue to refine these associations through large-scale, multi-ancestry genomic studies to ensure findings are accurate and applicable across diverse groups.
Population Frequency and Ancestry
The frequency of genetic variants like rs8103922 is highly variable across different global populations. Genetic ancestry plays a significant role in how common a specific allele is and how strongly it correlates with health outcomes. For instance, studies have shown that the risk associated with certain APOE variants can differ significantly between individuals of European, African, Hispanic, and Asian descent. Because of this, researchers are increasingly focused on conducting studies that include diverse participants to avoid bias and improve the generalizability of genetic findings. If you are reviewing your own genetic data, it is essential to recognize that population-level statistics describe trends in large groups rather than predicting the health of a single individual. Understanding these variations requires a nuanced view of how human history and migration have shaped the distribution of genetic markers across the globe.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs8103922 is primarily intended for educational and research purposes. You cannot use this information to diagnose yourself or others with a medical condition. If you have concerns about your cognitive health or family history, the most important step is to consult with a qualified healthcare professional, such as a neurologist or a genetic counselor. They can provide context based on your personal medical history, physical exams, and clinical testing. Furthermore, if you are considering genetic testing for medication response or disease risk, always discuss the implications and the necessity of such tests with your clinician or pharmacist. They can help you interpret results in a way that is clinically meaningful and relevant to your specific health needs. Genetic data is a tool for understanding biological risk, but it should always be integrated into a comprehensive care plan managed by medical experts.
How common is this variant?
The frequency of the rs8103922 variant is variable and depends significantly on an individual's ancestral background, as is common with many markers in the APOE locus.
Frequently asked questions
Does having a specific rs8103922 genotype mean I will get Alzheimer's?
No. Genetic variants are risk factors, not causes. Many people with various genotypes at this location never develop Alzheimer's, and the disease is influenced by many factors beyond genetics.
Should I get tested for APOE variants?
Genetic testing for APOE is generally not recommended for the general public. You should discuss the potential benefits and limitations of such testing with a doctor or genetic counselor if you have specific concerns.
How does ancestry affect my genetic risk?
Genetic ancestry can influence the frequency of certain variants and how they interact with other genes. Research shows that the impact of APOE variants can vary significantly between different ethnic and racial groups.
Where can I find more information about my specific genetic results?
If you have received results from a genetic testing service, consult with a healthcare provider or a certified genetic counselor. They can help you understand what your results mean in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/31/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs8103922?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOE
Variant in the APOE/TOMM40 locus associated with late-onset Alzheimer's disease risk.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.
Variant (c.497G>A, p.Arg166Gln) in the APOE gene known as Apolipoprotein E4 Christchurch, which has been shown in clinical case studies to confer resistance to familial Alzheimer's disease pathology.
Upstream regulatory variant influencing APOE transcription and plasma lipid modulation.
Defines the APOE ε2 allele, associated with lower LDL cholesterol and reduced risk of Alzheimer's disease.
Regulatory variant in the APOE promoter region modulating transcriptional activity and risk for late-onset neurodegeneration.